Janet Dorling

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Paul Quinlan, as attorney-in-fact for Janet Dorling
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Janet Dorling:

Company Role Class Num Shares Value Price $ Report Date Ownership
CymaBay Therapeutics, Inc. Director Common Stock 0 $0 $31.97 12 Feb 2024 Direct
CymaBay Therapeutics, Inc. Director Employee Stock Option (right to buy) 0 22 Mar 2024 Direct

Insider Reports Filed by Janet Dorling

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024035461-dorling-janet-2024-03-22 CymaBay Therapeutics, Inc. 22 Mar 2024 4 $0 4 Director 22 Mar 2024, 17:03
/report/000106299324003202-dorling-janet-2024-02-12 CymaBay Therapeutics, Inc. 12 Feb 2024 3 -$164,069 4 Director 14 Feb 2024, 18:43
/report/000106299324001421-dorling-janet-2024-01-24 CymaBay Therapeutics, Inc. 24 Jan 2024 1 $0 4 Director 26 Jan 2024, 18:19
/report/000106299324000776-dorling-janet-2024-01-10 CymaBay Therapeutics, Inc. 10 Jan 2024 3 -$115,364 4 Director 10 Jan 2024, 20:35
/report/000106299323022367-dorling-janet-2023-12-11 CymaBay Therapeutics, Inc. 11 Dec 2023 3 -$92,642 4 Director 11 Dec 2023, 19:01
/report/000106299323020834-dorling-janet-2023-11-10 CymaBay Therapeutics, Inc. 10 Nov 2023 3 -$74,290 4 Director 14 Nov 2023, 17:56
/report/000106299323001500-dorling-janet-2023-01-25 CymaBay Therapeutics, Inc. 25 Jan 2023 1 $0 4 Director 27 Jan 2023, 15:35
/report/000106299322001695-dorling-janet-2022-01-25 CymaBay Therapeutics, Inc. 25 Jan 2022 1 $0 4 Director 27 Jan 2022, 15:54